In those mice that experience a benefit, there was a prolonged period of slower tumor growth, which has been described as an unbalanced equilibrium of tumor cell proliferation and immune control.[27, 28] Utilizing both anti-CTLA4 and anti-OX40 together with radiation we observed extended survival including a proportion of mice cured of their tumors. Here, TNFRSF4 is linked to neoplasm.